We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.07%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$7.57B
AUM Growth
+$643M
(+9.3%)
Cap. Flow
+$235M
Cap. Flow
% of AUM
3.1%
Top 10 Holdings %
Top 10 Hldgs %
16.13%
Holding
1,154
New
305
Increased
228
Reduced
235
Closed
370
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$71M |
| 2 |
Baxter International
BAX
|
+$60.7M |
| 3 |
T-Mobile US
TMUS
|
+$60.1M |
| 4 |
Perrigo
PRGO
|
+$53.7M |
| 5 |
NRG Energy
NRG
|
+$50.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$68.2M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$53.3M |
| 3 |
Avient
AVNT
|
+$45.7M |
| 4 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$45.6M |
| 5 |
BHI
Baker Hughes
BHI
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.11% |
| 2 | Industrials | 11.84% |
| 3 | Consumer Discretionary | 11.65% |
| 4 | Technology | 10.61% |
| 5 | Financials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADVS
351
DELISTED
Advent Software Inc
ADVS
| $3.95M | 0.05% |
128,857
-142,110
| -52% | -$4.54M |
|
|
KATE
352
DELISTED
Kate Spade & Company
KATE
| $3.92M | 0.05% |
+122,400
| New | +$3.49M |
|
|
CYBX
353
DELISTED
CYBERONICS INC
CYBX
| $3.89M | 0.05% |
69,925
-11,815
| -14% | -$618K |
|
|
SHLM
354
DELISTED
Schulman (A.) Inc
SHLM
| $3.89M | 0.05% |
+95,921
| New | +$3.47M |
|
355
AerCap
AER
$24.4B
| $3.88M | 0.05% |
100,000
-122,514
| -55% | -$5.06M |
|
|
MLNX
356
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $3.88M | 0.05% |
90,729
+29,498
| +48% | +$1.28M |
|
357
Owens Corning
OC
$12.1B
| $3.84M | 0.05% |
107,347
+92,971
| +647% | +$3.09M |
|
358
Navigator Holdings
NVGS
$1.29B
| $3.84M | 0.05% |
182,424
+3,608
| +2% | +$79.1K |
|
359
Diamondback Energy
FANG
$53.1B
| $3.82M | 0.05% |
+63,885
| New | +$4.06M |
|
360
Hasbro
HAS
$12.9B
| $3.78M | 0.05% |
+68,791
| New | +$3.88M |
|
361
MGM Resorts International
MGM
$11.4B
| $3.71M | 0.05% |
173,768
+170,702
| +5,568% | +$3.71M |
|
362
James River Group Holdings
JRVR
$221M
| $3.71M | 0.05% |
+163,000
| New | +$3.59M |
|
|
SWN
363
DELISTED
Southwestern Energy Company
SWN
| $3.7M | 0.05% |
+135,431
| New | +$4.35M |
|
364
MSCI
MSCI
$41.2B
| $3.68M | 0.05% |
77,571
-237,811
| -75% | -$11.1M |
|
|
BEL
365
DELISTED
Belmond Ltd.
BEL
| $3.68M | 0.05% |
+297,298
| New | +$3.39M |
|
366
ArcBest
ARCB
$3.02B
| $3.63M | 0.05% |
78,366
-75,764
| -49% | -$3.08M |
|
367
Transocean
RIG
$5.71B
| $3.63M | 0.05% |
+197,939
| New | +$4.94M |
|
|
TIF
368
DELISTED
Tiffany & Co.
TIF
| $3.58M | 0.05% |
+33,534
| New | +$3.35M |
|
369
Commault Systems
CVLT
$5.53B
| $3.55M | 0.05% |
68,763
-51,237
| -43% | -$2.46M |
|
370
Skyworks Solutions
SWKS
$10.1B
| $3.52M | 0.05% |
48,464
-9,871
| -17% | -$612K |
|
371
IBM
IBM
$220B
| $3.44M | 0.05% |
+22,449
| New | +$3.57M |
|
372
ExxonMobil
XOM
$642B
| $3.42M | 0.05% |
37,005
-50,404
| -58% | -$4.7M |
|
|
CNV
373
DELISTED
CNOVA N.V.
CNV
| $3.38M | 0.04% |
+426,982
| New | +$3.08M |
|
|
ENDP
374
DELISTED
Endo International plc
ENDP
| $3.36M | 0.04% |
+46,619
| New | +$3.19M |
|
|
LTC
375
LTC Properties
LTC
$2.02B
| $3.35M | 0.04% |
77,537
-12,301
| -14% | -$503K |
|
Similar funds
Marshall Wace's Q4 2014 Portfolio in Review
As of Q4 2014, Marshall Wace held 1,154 positions worth $7.57B, up 9.3% from $6.93B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $235M of net new capital in Q4 2014, opening 305 new positions and adding to 228 existing holdings. Its largest new stake was Baxter International: 1,557,838 shares worth $62M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Alibaba, an estimated $68.2M trimmed.
- Marshall Wace's largest Q4 2014 buy was Baxter International: 1,557,838 shares worth $62M.
- Marshall Wace added most to Allergan Inc in Q4 2014, an estimated $71M increase.
- Marshall Wace's biggest Q4 2014 reduction was Alibaba, cutting an estimated $68.2M.
- Marshall Wace fully exited Baker Hughes in Q4 2014, selling an estimated $40.5M.
- Marshall Wace's ten largest holdings make up 16% of its $7.57B portfolio in Q4 2014.
- Marshall Wace opened 305 new positions and closed 370 in Q4 2014.
- Marshall Wace's portfolio value rose 9.3% quarter-over-quarter to $7.57B.
Based on Marshall Wace's 13F filing for Q4 2014, filed 17 Feb 2015.